๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

3 recruiting trials

for Thymoma Malignant Recurrent

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01) NCT04731610NA21 sites๐Ÿ“ Caen๐Ÿ“ Caen๐Ÿ“ Dijon Institut Curie ยท Tests: Radiotherapy, Surveillance after resection PT-112 in Subjects With Thymoma and Thymic Carcinoma NCT05104736Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: PT-112 First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) NCT05832827Phase 21 site๐Ÿ“ Chลซล National Cancer Center, Japan ยท Tests: MK-3475, Lenvatinib, Carboplatin, Paclitaxel
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy